Back to GetFilings.com



 

 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10–Q

(Mark one)

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002

 

OR

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM                      TO                     
COMMISSION FILE NO: 0-24567

 

NATROL, INC.
(Exact name of registrant as specified in its charter)

 

DELAWARE

 

95-3560780

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

21411 PRAIRIE STREET
CHATSWORTH, CALIFORNIA 91311

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

 

(818) 739–6000
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

 

INDICATE BY A CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS.
YES 
ý   NO  o

 

Indicate the number of shares outstanding of the issuer’s common stock, as of the latest practicable date:

 

Class

August 1, 2002

 

Common stock, $0.01 par value

12,853,714

 

 

 



 

 

PART 1. FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

NATROL, INC.
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS EXCEPT SHARE AND PER SHARE AMOUNTS)

 

 

 

June 30,

 

December 31,

 

 

 

2002

 

2001

 

 

 

(Unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

11,151

 

$

5,485

 

Accounts receivable, net of allowances of $506 and $363 at June 30, 2002 and December 31, 2001, respectively

 

8,434

 

6,787

 

Inventories

 

7,966

 

9,743

 

Deferred taxes

 

1,324

 

1,324

 

Income taxes receivable

 

 

1,408

 

Prepaid expenses and other current assets

 

1,140

 

1,826

 

Total current assets

 

30,015

 

26,573

 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

Building and improvements

 

15,607

 

15,625

 

Machinery and equipment

 

5,761

 

5,708

 

Furniture and office equipment

 

2,524

 

2,019

 

 

 

23,892

 

23,352

 

Accumulated depreciation and amortization

 

(6,282

)

(5,606

)

 

 

17,610

 

17,746

 

 

 

 

 

 

 

Goodwill, net of accumulated amortization of $24,123 at June 30, 2002 and December 31, 2001

 

8,215

 

8,215

 

Intangible assets, net of accumulated amortization of $2,600 and $2,300 at June 30, 2002 and December 31, 2001, respectively

 

6,469

 

6,769

 

Other assets

 

50

 

54

 

Total assets

 

$

62,359

 

$

59,357

 

 

See accompanying notes

 

2



 

 

 

 

June 30,

 

December 31,

 

 

 

2002

 

2001

 

 

 

(Unaudited)

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

4,992

 

3,372

 

Accrued expenses

 

5,188

 

4,240

 

Accrued payroll and related liabilities

 

574

 

494

 

Income taxes payable

 

310

 

 

Current portion of long-term debt

 

277

 

277

 

Total current liabilities

 

11,341

 

8,383

 

 

 

 

 

 

 

Deferred income taxes, noncurrent

 

251

 

251

 

Long-term debt, less current portion

 

7,944

 

8,083

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, par value of $0.01 per share:

 

 

 

 

 

Authorized shares — 2,000,000

 

 

 

 

 

Issued and outstanding shares — none

 

 

 

Common stock, par value of $0.01 per share:

 

 

 

 

 

Authorized shares — 50,000,000

 

 

 

 

 

Issued and outstanding shares — 13,775,614 and 13,712,354 at June 30, 2002 and December 31, 2001, respectively

 

138

 

137

 

Additional paid-in capital

 

61,988

 

61,869

 

Accumulated deficit

 

(16,422

)

(16,485

)

 

 

45,704

 

45,521

 

Shares held in treasury, at cost— 921,900 shares at June 30, 2002 and December 31, 2001

 

(2,881

)

(2,881

)

Total stockholders’ equity

 

42,823

 

42,640

 

Total liabilities and stockholders’ equity

 

$

62,359

 

$

59,357

 

 

See accompanying notes

 

3



 

NATROL, INC.
CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE AMOUNTS)

 

 

Three months ended

 

Six months ended

 

 

 

June 30,

 

June 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

 

 

(Unaudited)

 

(Unaudited)

 

Net sales

 

$

17,843

 

$

19,260

 

$

35,382

 

$

38,316

 

Cost of goods sold

 

10,744

 

11,295

 

21,704

 

22,568

 

Gross profit

 

7,099

 

7,965

 

13,678

 

15,748

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing expenses

 

4,325

 

3,519

 

8,058

 

7,353

 

General and administrative expenses

 

2,573

 

2,726

 

5,220

 

5,400

 

Total operating expenses

 

6,898

 

6,245

 

13,278

 

12,753

 

Operating income

 

201

 

1,720

 

400

 

2,995

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

26

 

27

 

45

 

93

 

Interest expense

 

(171

)

(209

)

(341

)

(481

)

Income before income tax provision

 

56

 

1,538

 

104

 

2,607

 

Income tax provision

 

20

 

618

 

41

 

1,030

 

Net income

 

$

36

 

$

920

 

$

63

 

$

1,577

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

0.00

 

$

0.07

 

$

0.00

 

$

0.12

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.00

 

$

0.07

 

$

0.00

 

$

0.12

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding — basic

 

12,842,714

 

12,742,282

 

12,838,365

 

12,791,880

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding — diluted

 

12,957,890

 

12,894,621

 

13,087,662

 

12,890,350

 

 

See accompanying notes

 

1



 

NATROL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE AMOUNTS)
(Unaudited)

 

 

Six Months Ended June 30,

 

 

 

2002

 

2001

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

Net income

 

$

63

 

$

1,577

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

676

 

720

 

Amortization of goodwill and intangibles

 

300

 

1,140

 

Provision for bad debts

 

235

 

307

 

Shares issued for services

 

14

 

6

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(1,882

)

695

 

Inventories

 

1,777

 

374

 

Income taxes receivable/payable

 

1,718

 

3,547

 

Prepaid expenses and other current assets

 

686

 

3

 

Accounts payable

 

1,620

 

758

 

Accrued expenses

 

947

 

(1,156

)

Accrued payroll and related liabilities

 

80

 

136

 

Net cash provided by operating activities

 

6,234

 

8,107

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

Purchases of property and equipment

 

(540

)

(135

)

Other assets

 

5

 

2

 

Net cash used in investing activities

 

(535

)

(133

)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Repayments on line of credit, net

 

 

(8,300

)

Repayments on long-term debt

 

(138

)

(109

)

Proceeds from stock purchase plan

 

7

 

2

 

Proceeds from exercise of stock options

 

98

 

 

Net cash used in financing activities

 

(33

)

(8,407

)

Net increase (decrease) in cash and cash equivalents

 

5,666

 

(433

)

Cash and cash equivalents, beginning of period

 

5,485

 

4,004

 

Cash and cash equivalents, end of period

 

$

11,151

 

$

3,571

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

Cash paid for interest

 

$

341

 

$

481

 

 

See accompanying notes

 

 

2



 

NATROL, INC.
NOTES TO CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
(ALL AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

 

1. BASIS OF PRESENTATION

 

In the opinion of management, the accompanying unaudited consolidated financial statements include all necessary adjustments (consisting of normal recurring accruals) and present fairly in all material respects the consolidated financial position of Natrol, Inc. and its subsidiaries (collectively, the “Company” or “Natrol”) as of June 30, 2002 and the results of its operations for the three and six months ended June 30, 2002 and 2001 and cash flows for the six months ended June 30, 2002 and 2001, in conformity with accounting principles generally accepted in the United States for interim financial information applied on a consistent basis. The results of operations for the three and six months ended June 30, 2002 are not necessarily indicative of the results to be expected for the full year.

 

Certain information and footnote disclosures which are normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted.  These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in Natrol’s December 31, 2001 audited consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2001 as filed with the Securities and Exchange Commission (file number 000–24567).

 

2. INVENTORIES

 

Inventories consist of the following:

 

 

 

June 30,

 

December 31,

 

 

 

2002

 

2001

 

 

 

 

 

 

 

Raw material and packaging supplies

 

$

3,499

 

$

4,280

 

Finished goods

 

4,467

 

5,463

 

 

 

$

7,966

 

$

9,743

 

 

3. COMPREHENSIVE INCOME

 

The Company’s comprehensive income items were not material at June 30, 2002 or December 31, 2001 and therefore no disclosures have been made.

 

4. SHIPPING AND HANDLING COSTS

 

Outbound shipping and fulfillment costs are classified as selling and marketing expenses and totaled $719 and $839 for the three months ended June 30, 2002 and 2001, respectively, and $1,452 and $1,575 for the six month periods ending June 30, 2002 and June 30, 2001, respectively.

 

3



 

5. EARNINGS PER SHARE

 

The Company calculates earnings per share in accordance with SFAS No. 128 “Earnings per share”.  Basic earnings per share has been computed by dividing net income by the weighted average number of common shares outstanding. Diluted earnings per share has been computed by dividing net income by the weighted average of securities or other contracts to issue Common Stock as if these securities were exercised or converted to Common Stock.  Common Stock equivalent shares from stock options representing 2,303,000 shares and 1,865,000 have been excluded from the computation of diluted earnings per share for the three months ending June 30, 2002 and for the six months ending June 30, 2002, respectively, because the effect would be antidilutive.

 

6. STOCKHOLDERS’ EQUITY

 

STOCK OPTIONS

 

Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation” encourages, but does not require, companies to record compensation cost for stock-based employee compensation plans at fair value. The Company has chosen to continue to account for stock-based compensation using the intrinsic value method prescribed in Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees.” During the three months ended June 30, 2002, 530,000 stock options were granted with exercise prices equal to the fair value of the underlying Common Stock on the date of grant.

 

7. CREDIT AGREEMENT

 

At June 30, 2002 and December 31, 2001 the Company was in violation of certain covenants in its line of credit agreement with Wells Fargo Bank, N.A.  During these periods the Company had no borrowings under its line of credit.  The line of credit agreement expired on July 15, 2002.

 

8. REVENUE RECOGNITION

 

The Company sells its products to retail outlets through a direct sales force and a national broker network. The Company recognizes revenue from sales only after product is shipped.  Net sales represent products shipped less returns, estimates for future returns, spoilage allowances, allowances for product deemed to be unsaleable by customers, and free goods shipped to customers for promotional or other purposes. Estimates and allowances are based upon known claims and an estimate of additional returns.

 

Effective January 1, 2002 the Company adopted the Financial Accounting Standards Board’s (FASB) Emerging Issues Task Force (EITF) Issue No. 01-9 “Accounting for Consideration Given by a Vendor to a Customer or Reseller of the Vendor’s Products,” which codified and reconciled the consensus reached on EITF Issue No. 00-14, “Accounting for Certain Sales Incentives,” EITF Issue No. 00-22 “Accounting for ‘Points’ and Certain Other Time-Based or Volume Based Sales Incentive Offers, and Offers of Free Products or Services to be Delivered in the Future,” and EITF Issue No. 00-25 “Vendor Income Statement Characterization of Consideration Paid to a Reseller of the Vendor’s Products.”  The guidance in these Issues is to be applied for financial statements for any period beginning after December 15, 2001. Under this pronouncement, slotting fees, rebates, price reduction scanbacks and miscellaneous other expense items which in effect reduce the cost of product to the Company’s customers must be deducted from gross sales revenue when calculating net sales revenue. As a result of the adoption of this EITF, net sales for the quarter ending June 30, 2001 have been reduced from $20.2 million to $19.2 million and net sales for the six months ended June 30, 2001 have been reduced from $40.0 million to $38.3 million with selling and marketing expenses being reduced by the same amount due to the reclassification of certain expenses from selling and marketing expenses to net sales.

 

4



 

9. ACCOUNTING FOR GOODWILL AND INTANGIBLES

 

The Company reviews the impairment of long-lived assets and certain identifiable intangibles whenever events or changes in circumstances indicate that the carrying amount of any asset may not be recoverable. An impairment loss would be recognized when the estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than the carrying amount. If an impairment is indicated, the amount of the loss to be recorded is based on an estimate of the difference between the carrying amount and the fair value of the asset. Fair value is based upon discounted estimated cash flows expected to result from the use of the asset and its eventual disposition and other valuation methods.

 

In June 2001, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 142, “Goodwill and Other Intangible Assets.” SFAS 142 prohibits the amortization of goodwill and intangibles with indefinite useful lives and requires these assets to be reviewed for impairment at least annually. Intangible assets with finite lives will continue to be amortized over their estimated useful lives. The Company began applying SFAS 142 in the first quarter of fiscal 2002 and application of the nonamortization provisions of this standard is expected to result in an increase in net income of $821,000 in 2002 on an annual basis. SFAS 142 requires testing of goodwill impairment under a two-step process. The first step is screen for potential impairment, while the second step measures the amount of impairment, if any.

 

During 2001, the Company reviewed the goodwill associated with its Laci Le Beau, EPI, and Prolab acquisitions.  The Company measured the valuation of the unamortized goodwill associated with these acquisitions relative to the market capitalization of the Company as a whole, relative to the undiscounted cash flows produced by these entities as well as potential future discounted cash flows with these cash flows being discounted by a required rate of return that took into account the risk-free rate of return as measured by the 20-year long bond rate of return as well as other measures of risk such as the Company’s small capitalization, risk associated with market size, volatility, historical cash flows and earnings, depth of management and other measures.

 

After the review, the Company determined that the unamortized goodwill associated with its Laci Le Beau acquisition was not impaired.  It further determined that in accordance with SFAS 142 no write down of this goodwill would be necessary in 2002 unless conditions surrounding this division’s performance change substantially.  In 2001, the Company amortized $340,000 relative to goodwill associated with its acquisition of Laci Le Beau. In the three and six months ending June 30, 2001, the Company recorded amortization of $85,000  and $170,000 relative to goodwill associated with its acquisition of Laci Le Beau.

 

The Company next determined that the unamortized goodwill associated with its acquisition of EPI was also not impaired.  However, the Company also determined that due to the nature of its supply agreement with ConAgra, which expires in approximately six years and the fact that ConAgra is EPI’s major source of supply for the majority of its business, the goodwill recorded related to the intangible value of the favorable terms of the contract acquired should be amortized. As such, this intangible is continuing to be amortized at the rate of $600,000 per year, consistent with the amount of goodwill amortized for EPI in 2001.

 

With respect to Prolab, the Company determined that it was appropriate to write down associated goodwill by $20 million during 2001. The Company considered all of the factors mentioned above but focused on the Prolab’s declining sales volume, issues surrounding Prolab’s ephedrine-based products, the Sports Nutrition market as a whole, and undiscounted cash flows.  Based on all of these considerations, the Company deemed that in accordance with accounting rules in effect in 2001 that a $20 million write down of goodwill was appropriate.  In addition, the Company reviewed the Prolab business and future expectations in accordance with SFAS 142.  The Company does not believe that a further write down of goodwill is necessary.  However, in accordance with SFAS 142, the Company will review the valuation of all of its goodwill during the third quarter of 2002 and it cannot guarantee that a further reduction of Prolab’s goodwill or a reduction of Laci Le Beau’s or EPI’s goodwill in addition to what has been described will not be necessary. In the three and six months ending June 30, 2001, the Company recorded amortization of $335,000 and $670,000 relative to goodwill associated with its acquisition of Prolab.

 

 

5



 

10. LONG-LIVED ASSETS

 

In August 2001, the FASB issued SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (SFAS 144), which addresses financial accounting and reporting for the impairment of long-lived assets and supercedes SFAS No. 121, “Accounting for the Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of,” and the accounting and reporting provisions of APB Opinion No. 30, “Reporting the Results of Operations — Reporting the Effects of a Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions,” for the disposal of a segment of a business. The Company adopted SFAS 144 in the first quarter of 2002 and the adoption of the statement had no effect on the Company’s financial position or results of operations.

 

11. RECLASSIFICATIONS

 

Certain reclassifications have been made to the 2001 consolidated financial statements to conform to the presentation in 2002.

 

ITEM 2:
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Information contained or incorporated by reference in this quarterly report on Form 10–Q and in other SEC filings by the Company contains “forward looking statements” within the meaning of  the  Private Securities Litigation Reform Act of 1995. The Company is including this statement for the express purpose of availing itself of protections of the safe harbor provided by the Private Securities Litigation Reform Act of 1995 with respect to all such forward looking statements. Examples of forward looking statements include, but are not limited to, the use of forward–looking terminology such as “believes,” “expects,” “may,” “will,” “should”, “intend”, “estimate”, “assume”, “plan” or “anticipates” or the negative thereof, other variations thereon, or comparable terminology, or by discussions of strategy that predict or indicate future events or trends or that are not historical facts. The Company cannot assure the future results or outcome of the matters described in these statements; rather, these statements merely reflect its current expectations of the approximate outcome of the matter discussed. The Company does not intend and undertakes no obligation to update any such statements at any time in the future.

 

The Company’s ability to predict results or the effect of certain events on the Company’s operating results is inherently uncertain. Forward–looking statements should not be unduly relied upon since they involve known and unknown risks, uncertainties and other factors, some of which are beyond the Company’s control. These risks, uncertainties and other factors may cause actual results, performance or achievements to differ materially from the anticipated future results, performance or achievements expressed or implied by such forward–looking statements. Therefore, the Company wishes to caution each reader of this report to carefully consider the following factors and certain other factors discussed herein and in other past reports, including but not limited to the prior year annual reports on Form 10-K filed with the Securities and Exchange Commission. The factors discussed herein and contained in that Form 10-K may not be exhaustive. Therefore, the factors contained herein should be read together with other reports and documents that are filed by the Company with the SEC from time to time, including Form 10-Q which may supplement, modify, supersede or update the factors listed in this document.

 

Factors that could cause or contribute to the Company’s actual results differing materially from those discussed herein or for the Company’s stock price to be affected adversely include, but are not limited to: (i) industry trends, including a general downturn or slowing of the growth of the dietary supplement industry which has occurred during recent years and may continue, (ii) increased competition from current competitors and new market entrants including but not limited to increased competition from private label house brands supported by retailers seeking to increase the market share of their proprietary house brands, (iii) adverse publicity regarding the dietary supplement industry or the Company’s products including recent publicity regarding ephedrine-based products, (iv) the Company’s dependence upon its ability to develop new products, (v) a continued high rate (or increase in the rate) of returns of the Company’s products, (vi) the Company’s ability to gain or expand or maintain distribution within new or existing customers and new or existing channels of trade, (vii) an increase in the cost of obtaining and maintaining shelf space with major national retailers who demand various

 

6



 

forms of incentives from their suppliers such as slotting fees, coop advertising, or rebates, (viii) adverse changes in government regulation, (ix) exposure to product liability claims including product liability claims from products which include ephedrine or other products for which the Company has either not been able to secure product liability coverage or been able to secure such coverage at reasonable prices., (as of June 30, 2002, the availability of product liability insurance for ephedrine-based products was non-existent and the Company expects substantial increases in the cost for product liability insurance as its policies renew during the second half of 2002), (x) dependence on significant customers, (xi) the Company’s ability to keep and attract key management employees, (xii) the Company’s inability to manage growth and execute its business plan, or the Company’s ability to modify its business plan in response to market conditions, including, but not limited to, its ability to enter new businesses and capitalize upon new business opportunities (xiii) the Company’s ability to consummate future acquisitions and its ability to integrate acquired businesses, including without limitation Prolab Nutrition, Inc. (“Prolab”), acquired in October, 1999 for which the Company took a $20 million impairment charge in the year ending December 31, 2001 due to the write down of goodwill associated with the acquisition, (xiv) the absence of conclusive clinical studies for many of the Company’s products, (xv) the Company’s inability to obtain raw materials that are in short supply including its ability to obtain garlic powders under its supply agreement with ConAgra for its Essentially Pure Ingredient (EPI) raw material sales division, (xvi) sales and earnings volatility, (xvii) volatility of the stock market (xviii) the Company’s ability to manufacture its products efficiently, (xix) the Company’s ability to manage inventory or sell its inventory before such inventory becomes outdated, (xx) the Company’s reliance on independent brokers to sell its products, (xxi) the inability of the Company to protect its intellectual property, (xxii) control of the Company by principal shareholders, (xxiii) the possible sale of large amounts of stock by controlling shareholders, (xxiv) a continued general downturn in the national economy as a whole, and (xxv) continued market acceptance of Natrol supplements, Laci Le Beau teas, Prolab’s sports nutrition products, and Essentially Pure Ingredients’ raw material products.

 

RESULTS OF OPERATIONS

 

THE FOLLOWING DISCUSSION OF THE RESULTS OF OPERATIONS AND FINANCIAL
CONDITION OF THE COMPANY SHOULD BE READ IN CONJUNCTION WITH THE RESPONSE TO PART I, ITEM 1 OF THIS REPORT.

 

THREE MONTHS ENDED JUNE 30, 2002 AND JUNE 30, 2001

 

NET SALES. Sales are recognized at the time product is shipped. Net sales are net of discounts, allowances, and estimated returns and credits, slotting fees, rebates and other expenses that reduce the cost of product to the Company’s customers.  Net sales decreased 7.4%, or $1.4 million, to $17.8 million for the three months ended June 30, 2002 from $19.3 million for the three months ended June 30, 2002.  The decline in net sales was primarily due to a lower volume of shipments as well as the Company providing for an increased level of returns stemming from inventory realignments at certain large mass market accounts. The market for nutritional supplements is very competitive and for the last two years industry trends have been negative. In this environment, major retail outlets have not been as willing as in past years to promote vitamins, minerals and supplements (VMS).  Many retailers reduced the amount of shelf space devoted to the VMS sector and retailers in general demanded higher levels of promotional support from vendors of VMS product. All of the factors mentioned above contributed to the decline in net sales for the quarter.

 

GROSS PROFIT.  Gross profit decreased 10.9%, or $866,000, to $7.1 million for the three months ended June 30, 2002 from $8.0 million for the three months ended June 30, 2001. Gross margin decreased to 39.8% for the three months ended June 30, 2002 from 41.4% for the three months ended June 30, 2001.  The decline was due to a higher percentage cost of materials and allocated overhead expenses relative to the dollar value of product shipped during the quarter.

 

SELLING AND MARKETING EXPENSES.  Selling and marketing expenses consist primarily of advertising and promotional expenses, cost of distribution, and related payroll expenses and commissions. Selling and marketing expenses increased 22.3%, or $805,000, to $4.3 million for the three months ended June 30, 2002 from $3.5 million for the three months ended June 30, 2001. The level of selling and

 

7



 

marketing expenditures in the quarter ending June 30, 2002 were higher due to an increased level of coop advertising and consumer print advertising than in the same quarter of 2001.

 

GENERAL AND ADMINISTRATIVE EXPENSES.  General and administrative expenses consist primarily of personnel costs related to general management functions, finance, accounting and information systems, research and development expenses, as well as professional fees related to legal, audit and tax matters and depreciation and amortization of goodwill. General and administrative expenses decreased 5.6%, or $153,000, and were approximately $2.6 million for the three months ended June 30, 2002. The decrease related primarily to a decrease in amortization of goodwill for the quarter ending June 30, 2002 to $150,000 as opposed to the $570,000 recorded in the quarter ended June 30, 2001 as a result of the application of SFAS 142. This decrease is partially offset by an increase in officers salaries. In the quarter ended June 30, 2001, Mr. Balbert, Natrol’s President, did not draw a salary whereas for the quarter ending June 30, 2002, Mr. Balbert’s salary amounted to $150,000.

 

INTEREST EXPENSE.  The Company recorded interest expense of $171,000 for the three months ended June 30, 2002 as compared to interest expense of $209,000 for the three months ended June 30, 2001. The Company pays interest on approximately $8.2 million of long-term mortgage debt as well as interest on its line of credit.  During the quarter ended June 30, 2002, the Company had no borrowings under its line of credit whereas in the quarter ended June 30, 2001, the Company had average borrowings of $1.7 million under its line of credit.

 

INCOME TAX PROVISION. The Company’s effective tax rate was approximately 36% in the second quarter of 2002 as opposed to 40% in the second quarter of 2001.  The change in the income tax provision at June 30, 2002 from June 30, 2001 is not considered significant by the Company and is due to temporary differences in the makeup of taxable and non-taxable expenses.

 

SIX MONTHS ENDED JUNE 30, 2002 AND JUNE 30, 2001

 

NET SALES. Net sales decreased 7.7%, or $2.9 million, to $35.4 million for the six months ended June 30, 2002 from $38.3 million for the six months ended June 30, 2001. The decline in net sales was primarily due to a lower volume of shipments as well as  the Company providing for an increased level of returns stemming from inventory realignments at certain large mass market accounts. The market for nutritional supplements is very competitive and for the last two years industry trends have been negative. In this environment, major retail outlets have not been as willing as in past years to promote vitamins, minerals and supplements (VMS).  Many retailers reduced the amount of shelf space devoted to the VMS sector and retailers in general demanded higher levels of promotional support from vendors of VMS product. All of the factors mentioned above contributed to the decline in net sales for the period.

 

GROSS PROFIT.  Gross profit declined 13.1%, or $2.0 million, to $13.7 million for the six months ended June 30, 2002 from $15.7 million for the six months ended June 30, 2001. Gross margin decreased to 38.7% for the six months ended June 30, 2002 from 41.1% for the six months ended June 30, 2001. The decline was due to a higher percentage cost of materials and allocated overhead expenses relative to the dollar value of product shipped during the period.

 

SELLING AND MARKETING EXPENSES.  Selling and marketing expenses consist primarily of advertising and promotional expenses, cost of distribution, and related payroll expenses and commissions. Selling and marketing expenses increased 9.6%, or $705,000, to $8.1 million for the six months ended June 30, 2002 from $7.4 million for the six months ended June 30, 2001. The level of selling and marketing expenditures in the six months ending June 30, 2002 were higher due to an increased level of coop advertising and consumer print advertising than in the same period of 2001.

 

GENERAL AND ADMINISTRATIVE EXPENSES.  General and administrative expenses consist primarily of personnel costs related to general management functions, finance, accounting and information systems, research and development expenses, as well as professional fees related to legal, audit and tax matters and depreciation and amortization. General and administrative expenses decreased 3.3%, or $181,000, to $5.2 million for the six months ended June 30, 2002 from $5.4 million for the six months

 

8



 

ended June 30, 2001. The decrease related primarily to a decrease in amortization of goodwill for the six months ending June 30, 2002 to $300,000 as opposed to the $1.1 million recorded in the six months ended June 30, 2001 as a result of the application of SFAS 142. This decrease is partially offset by an increase in officers salaries. In the six months ended June 30, 2001, Mr. Balbert, Natrol’s President, did not draw a salary whereas for the six months ending June 30, 2002, Mr. Balbert’s salary amounted to $300,000.  The only other significant change in general and administrative expenses were legal expenses which rose $477,000 when compared to the same period of 2001. The Company is currently defending itself in a number of trade and patent , product liability and regulatory lawsuits at this time.    Although the Company does not believe any one of these matters is material, the Company expects to incur higher legal expenses as it defends these lawsuits in future periods.  Litigation is inherently uncertain and as a result, there can be no assurance that, if these or other lawsuits are decided adversely to the Company, it would not have a materially adverse effect on the Company’s financial condition and results of operations.

 

 

INTEREST EXPENSE.  Interest expense decreased to $341,000 for the six months ended June 30, 2002 from $481,000 for the six months ended June 30, 2001. The Company pays interest on approximately $8.2 million of long-term mortgage debt as well as interest on its line of credit.  During the six months ended June 30, 2002, the Company had no borrowings under its line of credit whereas in the six months ended June 30, 2001, the Company had average borrowings of $4.1 million under its line of credit.

 

INCOME TAX PROVISION. The Company’s effective tax rate increased to 39.7% in the six months ended June 30, 2002 from 39.5% in the six months ended June 30, 2001.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At June 30, 2002, the Company had working capital of $18.7 million, as compared to $18.2 million in working capital at December 31, 2001. The Company’s cash balance at June 30, 2002 was approximately $11.2 million.

 

Net cash provided by operating activities was $6.2 million for the six months ended June 30, 2002 versus net cash provided of $8.1 million for the six months ended June 30, 2001. Cash provided by operating activities during the six month period ended June 30, 2002 was primarily due to a decrease in inventory levels of $1.8 million, a reduction in income taxes receivable of $1.7 million, an increase in trade payables and accrued expenses of  $2.6 million, depreciation and amortization of $976,000 and a reduction in prepaid expenses of $686,000 offset by increases in accounts receivable of $1.9 million.

 

Net cash used in investing activities was $535,000 for the six months ended June 30, 2002 and $133,000 during the six months ended June 30, 2001. Nearly all of the cash used in  investing activities in both periods was in property and equipment.

 

Net cash used by financing activities was $33,000 for the six months ended June 20, 2002 as opposed to $8.4 million used by financing activities during the six months ended June 30, 2001. During the six months ended June 30, 2002, the Company made principal payments of $138,000 on its long-term mortgage debt and received $105,000 from the proceeds of the exercise of stock options and the sale of stock to employees through its employee stock purchase program.  During the six months ended June 30, 2001, the Company reduced its line of credit by $8.3 and repaid $109,000 in long-term debt.

 

As of June 30, 2002, the Company had $8.2 million of outstanding debt all of which is the result of a mortgage on the Company’s manufacturing/headquarters facility and a mortgage on the Company’s shipping facility.

 

At June 30, 2002, the Company was out of compliance with certain financial ratios contained in its line of credit. This line of credit expired on July 15, 2002.  As of the filing of this report, the Company was not in negotiations to re-establish its line of credit.  As of June 30, 2002 the Company’s cash balance was approximately $11.2 million.

 

9



 

If the Company is unable to re-establish a line of credit or obtain additional financing, its sources of liquidity will be reduced.  If the Company were to seek or obtain additional debt financing, potential lenders may seek to institute covenants restricting the Company from certain activities. If the Company deems it necessary to borrow funds with these restrictions in place,  its ability to compete effectively in its market sector and to otherwise operate its business may be hindered

 

Regardless of its ability to borrow additional funds, the Company believes that its current cash balance together with cash generated from operations will be sufficient to fund its anticipated working capital needs and capital expenditures for the next 12 months.

 

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The following discussion about the Company’s market risk disclosures involves forward–looking statements. Actual results could differ materially from those projected in the forward–looking statements. The Company does not believe it is exposed to market risk related to changes in interest rates. The risks related to foreign currency exchange rates are immaterial and the Company does not use derivative financial instruments.

 

The Company currently has no short-term borrowings and as of July 15, 2002 it had no line of credit established with any lender.  The Company does not believe that the risk is significant for its long-term debt due to the low fixed rates and insignificance of the long-term debt to the Company’s consolidated balance sheet.

 

PART II

OTHER INFORMATION

 

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

a)

 

The 2001 Annual Meeting of Stockholders of Natrol, Inc. (the “Annual Meeting”) was held on June 14, 2002.

 

b)

 

At the Annual Meeting, the following were re-elected to the Company’s Board of Directors:

 

 

 

 

 

 

 

 

 

 

Votes For

 

Votes Withheld

 

 

 

 

 

 

 

 

 

 

Dennis Jolicoeur

12,300,566

 

85

 

 

The following individuals are members of the Company’s Board of Directors whose terms of office as directors continued after the Annual Meeting. 

 

Elliott Balbert
Dennis De Concini
Vernon Brunner
Dennis Griffin
Dennis Jolicoeur

 

Mr. Griffin resigned his position on August 1, 2002 and on that date joined the Company as President of the Company’s Essentially Pure Ingredients division.

 

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

 

Exhibit 99.1

 

Certification of Chief Financial Officer

Exhibit 99.2

 

Certification of President/CEO/Chairman

 

No reports on Form 8-K were filed during the quarter for which this report is filed

 

10



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

NATROL, INC.

 

 

 

Date: 8/14/02

By:

/s/ Elliott Balbert

 

 

Chairman, President and Chief Executive Officer

 

 

 

Date: 8/14/02

By:

/s/ Dennis R. Jolicoeur

 

 

Chief Financial Officer and Executive
Vice President

 

 

 

 

 

11